Relapse of IgG4-related nephritis following mRNA COVID-19 vaccine
- 8 June 2021
- journal article
- letter
- Published by Elsevier BV in Kidney International
- Vol. 100 (2), 465-466
- https://doi.org/10.1016/j.kint.2021.06.002
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Relapse of primary membranous nephropathy after inactivated SARS-CoV-2 virus vaccinationKidney International, 2021
- Minimal change disease relapse following SARS-CoV-2 mRNA vaccineKidney International, 2021
- IgG4-related disease: an update on pathophysiology and implications for clinical careNature Reviews Rheumatology, 2020
- Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patientsPLOS ONE, 2017